Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer—Reply

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally... Letters suicide may be researched with treating cancer patients in the drug(s). There are other safeguards, including the fact mind, but it never stops there. In addition, people who can- that the patient must make 3 different requests for lethal not advocate for themselves such as patients in coma situa- medication, and that 2 physicians must certify that he or she tions or with severe intellectual disabilities are put at risk is competent and understands the ramifications of that when hospitalized because a physician may judge that their request. There is no opportunity under the law for even the pain and low quality of life makes them a candidate for most misguided physician or family member to involuntarily involuntary euthanasia. This is a breach of the trust rela- force MAID on a patient. tionship between patient and physician that society cannot Finally, Ms Sperling’s statement “it never stops there” is afford to accept. incorrect. Under the law, MAID is exactly where it stops. There are no risks to “patients in a coma,” those with intellectual or Sarah K. Sperling, BA psychiatric disabilities, or patients with nonterminal condi- tions. It is illegal for a physician (or anyone else, for that http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer—Reply

Loading next page...
 
/lp/jama/prostate-specific-membrane-antigen-positron-emission-tomography-3FD3IPgaHQ
Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
D.O.I.
10.1001/jamaoncol.2017.5340
Publisher site
See Article on Publisher Site

Abstract

Letters suicide may be researched with treating cancer patients in the drug(s). There are other safeguards, including the fact mind, but it never stops there. In addition, people who can- that the patient must make 3 different requests for lethal not advocate for themselves such as patients in coma situa- medication, and that 2 physicians must certify that he or she tions or with severe intellectual disabilities are put at risk is competent and understands the ramifications of that when hospitalized because a physician may judge that their request. There is no opportunity under the law for even the pain and low quality of life makes them a candidate for most misguided physician or family member to involuntarily involuntary euthanasia. This is a breach of the trust rela- force MAID on a patient. tionship between patient and physician that society cannot Finally, Ms Sperling’s statement “it never stops there” is afford to accept. incorrect. Under the law, MAID is exactly where it stops. There are no risks to “patients in a coma,” those with intellectual or Sarah K. Sperling, BA psychiatric disabilities, or patients with nonterminal condi- tions. It is illegal for a physician (or anyone else, for that

Journal

JAMA OncologyAmerican Medical Association

Published: May 22, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off